Ironwood Pharmaceuticals
IRWD
129 hedge funds and large institutions have $2.05B invested in Ironwood Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 45 increasing their positions, 42 reducing their positions, and 19 closing their positions.
157% more call options, than puts
Call options by funds: $1.77M | Put options by funds: $688K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
20% more capital invested
Capital invested by funds: $1.71B → $2.05B (+$337M)
7% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 42
8% less funds holding
Funds holding: 140 → 129 (-11)
47% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$22.6M |
| 2 |
Millennium Management
New York
|
+$18.2M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$16.9M |
| 4 |
SAM
Senzar Asset Management
New York
|
+$10.7M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$15.6M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
-$10.7M |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$8.17M |
| 4 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$7.41M |
| 5 |
VAM
Visium Asset Management
New York
|
-$7.13M |
IRWD Hedge Fund Activity: Q4 2014 in Review
129 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2014, worth a combined $2.05B — up 20% from $1.71B a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of IRWD and 10 opened new positions — a net loss of 9 holders — while 42 trimmed existing stakes and 45 added.
The largest buyer was Deutsche Bank, adding an estimated $22.6M. The largest seller was State of Wisconsin Investment Board, cutting an estimated $15.6M.
- 129 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2014, down from 140 in Q3 2014.
- Funds reported $2.05B of Ironwood Pharmaceuticals stock for Q4 2014, up 20% quarter-over-quarter.
- 10 funds opened new Ironwood Pharmaceuticals positions in Q4 2014 and 19 closed out, a net change of -9 holders.
- The largest Ironwood Pharmaceuticals buyer in Q4 2014 was Deutsche Bank, an estimated $22.6M added.
- The largest Ironwood Pharmaceuticals seller in Q4 2014 was State of Wisconsin Investment Board, an estimated $15.6M sold.
Based on aggregated 13F filings for Q4 2014.